Dr. Tyna Moore

🌎 The WORLD’S FIRST Transcriptomic Evidence of Alarming System-Wide Disruption Post mRNA Vaccination A landmark preprint by Natalia von Ranke, Wei Zhang, Philipp Anokhin, Minh Vu, Nicolas Hulscher, Kevin J. McKernan, Peter A. McCullough, and John A. Catanzaro* 🚨Is shaking the core of global molecular science: “Synthetic mRNA Vaccines and Transcriptomic Dysregulation” preprints.org/manuscript/202… This is the first-ever transcriptomic surveillance framework (REViSS) applying molecular forensics to patients presenting aggressive cancers, immune collapse, cardiovascular and neurologic rapid decline post‑vaccination. Critical RNA‑seq revelations: •Mitochondrial bioenergetic collapse •MYC, mTOR, and FOXO pathway activation •Ribosomal stress, proteostasis failure •Synthetic mRNA sequences embedded in host expression profiles •Hallmarks of oncogenic and neurodegenerative transitions This is not correlation—it’s cellular‑level transcriptomic evidence of synthetic mRNA-induced sabotage. REViSS (RNA Expression Variant Instability Signature Surveillance) inaugurates a new frontier in post‑vaccine molecular aberration. ‼️Already ranked among the most viewed and downloaded preprints globally. Stirring heated debate across science, bioethics, and regulatory circles. Redefining mRNA risk models at the molecular scale to enable precision-driven, personalized mitigation strategies. @P_McCulloughMD @McCulloughFund @NicHulscher @Kevin_McKernan

I want to address those of you who have anxieties about @US_FDA’s limited approval of a new mRNA COVID vaccine for high-risk populations. Moderna has agreed to a true placebo-controlled trial of the new vaccine, which is similar to the existing mRNA vaccine but uses a smaller protein. The FDA will monitor and collect data throughout the trial for every adverse outcome—not just a table list of expected outcomes. FDA will scrutinize every aspect of the trial. We will deliver on our promise to use gold standard science and common sense.